News and events

Spotlight news

6 January 2025

A fond farewell as Graham retires

Graham Shelton, our Founder and Chairman, stepped down at the end of December 2024. We were proud to mark his retirement at our Oxford party, and present him with a book of memories from current and former colleagues and clients from around the world.

All
  • All
  • News
  • Articles
  • Events

Best practice in medical communications: insights from the 42nd European Medical Writers Association Conference

Medical writers from across Europe gathered in Munich at the 42nd European Medical Writers Association Conference (EMWA, 10–14 May 2016) to network, share best practice and look to the future.

Continue reading

Oxford PharmaGenesis draws the crowds at the 12th Annual Meeting of ISMPP

Oxford PharmaGenesis joined this year’s International Society for Medical Publication Professionals Annual Meeting (ISMPP, 11–13 April, 2016; National Harbor, MD, USA), which attracted over 500 publication professionals from the pharmaceutical industries, medical communication agencies, and publishers from around the globe. The attendees were Gordon Muir-Jones, Brian Falcone, Shilpa Aggarwal, Philip Joseph, and Scott Forbes from…

Continue reading

Disclosure of individual-patient data: time to put the patient first

The International Committee of Medical Journal Editors (ICMJE) is consulting on a proposal that authors reporting clinical trials in member journals will be required to share the underlying de-identified individual-patient data with others (Taichman et al., 2016). We believe that this proposal pays insufficient attention to the unique needs of the patients who take part…

Continue reading

Privilege walk for rare diseases

Privilege (/ˈprɪvəlɪdʒ/) ‘A special right, advantage or immunity granted or available only to a particular person or group.’ We all know what privilege is, but it can be difficult to appreciate fully how privilege – or the lack thereof – can affect us. It is especially difficult to understand the challenges faced by people with…

Continue reading

PharmaTimes highlights Oxford PharmaGenesis rare disease insights

Oxford PharmaGenesis expertise in rare diseases was showcased in the April edition of PharmaTimes. The article ‘Time To Think Rare’ quoted Commercial Director Dr Richard White (http://tinyurl.com/hhk3xme) alongside other well-known figures in the rare diseases arena, including Alastair Kent (Director of the Genetic Alliance and Chair of Rare Disease UK) and Kay Parkinson (Chief Executive…

Continue reading

Oxford PharmaGenesis educates the next generation of value demonstration communicators at the 2nd Annual HEOR Writing Workshop

Oxford PharmaGenesis employees past and present were at the centre of the 2nd Annual HEOR Writing Workshop, held in Philadelphia on 17‑18 March 2016 and run by HealthEconomics.com and the Global Outcomes Group with sponsorship from the Mayes College of Healthcare Business and Policy. Attended by a mix of industry, agency and freelance medical writers,…

Continue reading